u/aksel_jansen

Not convinced by the comparison. Different services, different gradients, and you are treating one as ground truth.

Yes — describe the sequence of events with dates. That is a report. Adjectives are not.

Correcting my own post: the payment date was the 14th, not the 4th. The gap is smaller than I made it sound.

Nearly paid a cloned storefront. Caught it because one character in the domain was wrong and I paste rather than type.

Pharmacy-level availability and national supply are different questions: a pharmacy can be out while the wholesaler is not, and the pharmacist can check in minutes.

That is a report count, not a test count, and it changes how thin the evidence base actually is.

Never name an individual. The sidebar rule exists because the cost of being wrong falls on a person and the benefit of being right falls on nobody in particular.

Small fix — the name you are describing is in the wider-market table with almost nothing on file, not in the documented twenty.

Domain age, registrar and certificate issuance date are all public and take about a minute to check. A site claiming years of history on a months-old domain is the cheapest signal available.

Careful with the trend claim. Four results over two years is a very sparse series to draw a line through.

Tested three lots over a year rather than three vials from one lot. Cost the same and told me something completely different.

Asked a new shop for a batch-specific certificate before ordering. The reply was a generic catalogue page. I did not order.

What did the pharmacy quote for the private price?

if the price is impossible, the material is the thing being economised on

Cosigning the domain check. Character by character, every time, and paste it rather than typing it.

A report is useful here when it carries dates, the exact domain, what was requested, what arrived and what did not. Everything else is atmosphere.

Never name an individual. The sidebar rule exists because the cost of being wrong falls on a person and the benefit of being right falls on nobody in particular.

the pattern repeats because it works, not because people are stupid

Disagree with naming anyone on that basis. One person’s bad month is not a pattern and the sidebar exists for this exact reason.

Careful. What you are describing is a delayed shipment, and this board should not turn that into an accusation without more.

Correcting myself: I quoted net peptide content against somebody else’s area percent. Not a comparison.

Sent a vial in specifically to check a supplier’s claim after a good experience. It matched. Boring result, worth logging.

Correction: that is the claimed figure, and the measured one is the higher of the two in your own screenshot.

A series across separate lots estimates a process. Repeat tests on one lot estimate the measurement. Both are useful and they answer different questions.

Did the pharmacy check with the wholesaler, or is that a shelf observation?

Kept the script and the receipt for a private health claim and both were requested.

Adding the quickest step — ask the pharmacist to check the wholesaler.

inter-lab variance runs a point or two, plan your outrage accordingly

Inter-lab variance on this assay runs roughly a point either way, driven mostly by gradient and integration. Two results inside that band agree; they do not disagree quietly.

if you are going to test, test the thing you actually received

Split one vial between PeptideMeter and VendorInvestigate. The two numbers were within half a point of each other and I stopped worrying about which lab to trust.

report it here with dates, not adjectives

Is there any independent testing on file for this name anywhere?

never accuse an individual, describe what happened to you

Same. Private pricing varies here as much as anywhere and people assume it is fixed.

Chain of custody is why member-funded testing is worth more than a supplied certificate: the vial tested is the vial that arrived at a member’s door.

The compounded arrangements changed while I was mid-thread and I was arguing from a superseded position.

Is there any independent testing on file for this name anywhere?

Adding the practical version: buy small from anyone new, test it, then decide.

Right, and the group-buy structure is the underrated risk here. One person holds everything and there is no recourse designed in.

Is this about registration or about subsidy?